Relationship Between Metabolic Syndrome and Polycystic Ovary Syndrome with Special Reference to C-Reactive Protein

被引:1
作者
Alissa, Eman M. [1 ]
Algarni, Samiah A. [1 ]
Khaffji, Azza J. [2 ]
Mansouri, Nisma M. Al [3 ]
机构
[1] King Abdulaziz Univ, Fac Med, Dept Clin Biochem, Jeddah, Saudi Arabia
[2] King Abdulaziz Hosp, Dept Obstet & Gynecol, Jeddah 21589, Saudi Arabia
[3] King Abdulaziz Univ, Fac Med, Obstet & Gynecol Dept, Jeddah, Saudi Arabia
关键词
BMI; CRP; HOMA-IR; WC; WHR; WHtR; IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; CARDIOVASCULAR RISK; ANDROGEN EXCESS; WOMEN; PREVALENCE; PCOS; OBESITY; INFLAMMATION; ASSOCIATION;
D O I
10.1016/j.jogc.2023.102255
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objectives: To estimate C -reactive protein (CRP) levels in Saudi women with and without polycystic ovary syndrome (PCOS), and to investigate the associations between CRP and metabolic syndrome (MetS) components. Methods: We randomly recruited 200 women with and without PCOS, between 18 and 38 years, in this age-matched case -control study. Study subjects were allocated to 1 of 4 groups according to the presence or absence of MetS. Interviews were conducted with all participants, and anthropometric measurements and blood samples were obtained for subsequent analysis of biochemical variables. Results: Two-thirds of the study population and all study subjects had central obesity. Fasting insulin and homeostasis model assessment insulin resistance index were significantly higher in PCOS and MetS groups than all other groups ( P < 0.05). CRP levels were significantly higher among women with PCOS than their age-matched controls, regardless of the presence of MetS ( P < 0.05). Body mass index was the only independent predictor of serum high-sensitivity-CRP, accounting for 17% of the variability in circulating levels (b = 0.407; 95% CI 0.248e0.472, P < 0.0001). Conclusions: Obesity and insulin resistance are important risk factors for MetS in PCOS. The presence of MetS in PCOS subjects aggravates the proinflammatory state reflected by CRP levels.
引用
收藏
页数:6
相关论文
共 25 条
[11]   Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome [J].
Ehrmann, DA ;
Liljenquist, DR ;
Kasza, K ;
Azziz, R ;
Legro, RS ;
Ghazzi, MN .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (01) :48-53
[12]   Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group [J].
Fauser, Bart C. J. M. ;
Tarlatzis, Basil C. ;
Rebar, Robert W. ;
Legro, Richard S. ;
Balen, Adam H. ;
Lobo, Roger ;
Carmina, Enrico ;
Chang, Jeffrey ;
Yildiz, Bulent O. ;
Laven, Joop S. E. ;
Boivin, Jacky ;
Petraglia, Felice ;
Wijeyeratne, C. N. ;
Norman, Robert J. ;
Dunaif, Andrea ;
Franks, Stephen ;
Wild, Robert A. ;
Dumesic, Daniel ;
Barnhart, Kurt .
FERTILITY AND STERILITY, 2012, 97 (01) :28-U84
[13]   Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians [J].
Forouhi, NG ;
Sattar, N ;
McKeigue, PM .
INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (09) :1327-1331
[14]   Urinary sex hormone excretions in premenopausal women and coronary heart disease risk: A nested case-referent study in the DOM-cohort [J].
Gorgels, WJMJ ;
vanderGraaf, Y ;
Blankenstein, MA ;
Collette, HJA ;
Erkelens, DW ;
Banga, JD .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1997, 50 (03) :275-281
[15]   Controversy in clinical endocrinology - Metabolic syndrome: A multiplex cardiovascular risk factor [J].
Grundy, Scott M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (02) :399-404
[16]   Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [J].
Grundy, SM ;
Cleeman, JI ;
Daniels, SR ;
Donato, KA ;
Eckel, RH ;
Franklin, BA ;
Gordon, DJ ;
Krauss, RM ;
Savage, PJ ;
Smith, SC ;
Spertus, JA ;
Costa, F .
CIRCULATION, 2005, 112 (17) :2735-2752
[17]   Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women [J].
Legro, RS ;
Kunselman, AR ;
Dodson, WC ;
Dunaif, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01) :165-169
[18]   No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls [J].
Lindholm, Asa ;
Blomquist, Caroline ;
Bixo, Marie ;
Dahlbom, Ingrid ;
Hansson, Tony ;
Poromaa, Inger Sundstrom ;
Buren, Jonas .
HUMAN REPRODUCTION, 2011, 26 (06) :1478-1485
[19]  
Mahadik Sujata R., 2008, Metabolic Syndrome and Related Disorders, V6, P121, DOI 10.1089/met.2007.0034
[20]   Targets to treatmetabolic syndrome in polycystic ovary syndrome [J].
Mahalingaiah, Shruthi ;
Diamanti-Kandarakis, Evanthia .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (11) :1561-1574